Cargando…
Safe and stable generation of induced pluripotent stem cells using doggybone DNA vectors
The application of induced pluripotent stem cells (iPSCs) in advanced therapies is increasing at pace, but concerns remain over their clinical safety profile. We report the first-ever application of doggybone DNA (dbDNA) vectors to generate human iPSCs. dbDNA vectors are closed-capped linear double-...
Autores principales: | Thornton, Christopher D., Fielding, Stuart, Karbowniczek, Kinga, Roig-Merino, Alicia, Burrows, Alysha E., FitzPatrick, Lorna M., Sharaireh, Aseel, Tite, John P., Mole, Sara E., Harbottle, Richard P., Caproni, Lisa J., McKay, Tristan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546411/ https://www.ncbi.nlm.nih.gov/pubmed/34729381 http://dx.doi.org/10.1016/j.omtm.2021.09.018 |
Ejemplares similares
-
CAR T Cell Generation by piggyBac Transposition from Linear Doggybone DNA Vectors Requires Transposon DNA-Flanking Regions
por: Bishop, David C., et al.
Publicado: (2020) -
Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre-clinical model
por: Allen, Alex, et al.
Publicado: (2018) -
Production of lentiviral vectors using novel, enzymatically produced, linear DNA
por: Karda, Rajvinder, et al.
Publicado: (2019) -
Novel synthetic plasmid and Doggybone™ DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice
por: Scott, Veronica L, et al.
Publicado: (2015) -
SARS-CoV-2 Doggybone DNA Vaccine Produces Cross-Variant Neutralizing Antibodies and Is Protective in a COVID-19 Animal Model
por: Mucker, Eric M., et al.
Publicado: (2022)